Fenoldopam to prevent renal replacement therapy after cardiac surgery. Design of the FENO-HSR study

INTRODUCTION: Acute kidney injury requiring renal replacement therapy is a serious complication following cardiac surgery associated with poor clinical outcomes. Until now no drug showed nephroprotective effects. Fenoldopam is a dopamine-1 receptor agonist which seems to be effective in improving po...

Descripción completa

Detalles Bibliográficos
Autores principales: Landoni, G, Bove, T, Pasero, D, Comis, M, Orando, S, Pinelli, F, Guarracino, F, Corcione, A, Galdieri, N, Zucchetti, M, Maglioni, E, Biagioli, B, Pala, G, Frontini, M, Caramelli, F, Persi, B, Renzini, M, Paoletti, F, Lorini, L, Morelli, A, Alvaro, G, Bianco, R, Pittarello, D, Manzato, A, Pedersini, G, Mizzi, A, Lojacono, N, Leoncini, P, Iovino, T, Cariello, C, Baldassarri, R, Camata, A M, Padua, G, Frascaroli, G, Leonardi, S, Bignami, E, Zangrillo, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDIMES Edizioni Internazionali Srl 2010
Materias:
Research-Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484615/
https://www.ncbi.nlm.nih.gov/pubmed/23440680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484615/
https://www.ncbi.nlm.nih.gov/pubmed/23440680

Ejemplares similares